OUSTER INC (OUST)

US68989M2026 - Common Stock

14.64  +2.29 (+18.54%)

After market: 14.5999 -0.04 (-0.27%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to OUST. OUST was compared to 126 industry peers in the Electronic Equipment, Instruments & Components industry. While OUST seems to be doing ok healthwise, there are quite some concerns on its profitability. OUST is valued quite expensively, but it does show have an excellent growth rating.



1

1. Profitability

1.1 Basic Checks

OUST had negative earnings in the past year.
OUST had a negative operating cash flow in the past year.
OUST had negative earnings in each of the past 5 years.
OUST had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of OUST (-44.00%) is worse than 83.47% of its industry peers.
OUST's Return On Equity of -65.39% is on the low side compared to the rest of the industry. OUST is outperformed by 80.99% of its industry peers.
Industry RankSector Rank
ROA -44%
ROE -65.39%
ROIC N/A
ROA(3y)-65.92%
ROA(5y)-111.47%
ROE(3y)-108.34%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 31.06%, OUST perfoms like the industry average, outperforming 50.41% of the companies in the same industry.
OUST's Gross Margin has improved in the last couple of years.
OUST does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y13.3%
GM growth 5YN/A

6

2. Health

2.1 Basic Checks

OUST does not have a ROIC to compare to the WACC, probably because it is not profitable.
OUST has more shares outstanding than it did 1 year ago.
The debt/assets ratio for OUST has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 0.02, we must say that OUST is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.02, OUST is doing worse than 80.99% of the companies in the same industry.
There is no outstanding debt for OUST. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.02
ROIC/WACCN/A
WACC10.52%

2.3 Liquidity

OUST has a Current Ratio of 3.12. This indicates that OUST is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.12, OUST is in the better half of the industry, outperforming 61.16% of the companies in the same industry.
OUST has a Quick Ratio of 2.83. This indicates that OUST is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 2.83, OUST is doing good in the industry, outperforming 69.42% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.12
Quick Ratio 2.83

7

3. Growth

3.1 Past

OUST shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 70.22%, which is quite impressive.
Looking at the last year, OUST shows a very strong growth in Revenue. The Revenue has grown by 51.12%.
The Revenue has been growing by 63.94% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)70.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%39.33%
Revenue 1Y (TTM)51.12%
Revenue growth 3Y63.94%
Revenue growth 5YN/A
Sales Q2Q%26.41%

3.2 Future

The Earnings Per Share is expected to grow by 25.69% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 69.79% on average over the next years. This is a very strong growth
EPS Next Y70.65%
EPS Next 2Y30.73%
EPS Next 3Y20.29%
EPS Next 5Y25.69%
Revenue Next Year33.9%
Revenue Next 2Y32.42%
Revenue Next 3Y39.02%
Revenue Next 5Y69.79%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OUST. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OUST. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

OUST's earnings are expected to grow with 20.29% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.73%
EPS Next 3Y20.29%

0

5. Dividend

5.1 Amount

No dividends for OUST!.
Industry RankSector Rank
Dividend Yield N/A

OUSTER INC

NASDAQ:OUST (1/3/2025, 8:00:02 PM)

After market: 14.5999 -0.04 (-0.27%)

14.64

+2.29 (+18.54%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)N/A N/A
Inst Owners38.39%
Inst Owner Change16.84%
Ins Owners5.27%
Ins Owner Change1.03%
Market Cap728.63M
Analysts80
Price Target11.63 (-20.56%)
Short Float %9.6%
Short Ratio3.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.26%
Min EPS beat(2)7.66%
Max EPS beat(2)16.86%
EPS beat(4)3
Avg EPS beat(4)9.38%
Min EPS beat(4)-12.21%
Max EPS beat(4)25.21%
EPS beat(8)4
Avg EPS beat(8)-8.64%
EPS beat(12)5
Avg EPS beat(12)-7.86%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.94%
Min Revenue beat(2)-2.1%
Max Revenue beat(2)-1.79%
Revenue beat(4)0
Avg Revenue beat(4)-1.09%
Min Revenue beat(4)-2.1%
Max Revenue beat(4)-0.06%
Revenue beat(8)2
Avg Revenue beat(8)-4.04%
Revenue beat(12)3
Avg Revenue beat(12)-6.07%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.79%
PT rev (3m)-1.72%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.63%
EPS NY rev (1m)0%
EPS NY rev (3m)2.07%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-10.37%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.11%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.91
P/FCF N/A
P/OCF N/A
P/B 4.24
P/tB 4.78
EV/EBITDA N/A
EPS(TTM)-2.57
EYN/A
EPS(NY)-2.23
Fwd EYN/A
FCF(TTM)-1.17
FCFYN/A
OCF(TTM)-1.11
OCFYN/A
SpS2.12
BVpS3.45
TBVpS3.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -44%
ROE -65.39%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.06%
FCFM N/A
ROA(3y)-65.92%
ROA(5y)-111.47%
ROE(3y)-108.34%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y13.3%
GM growth 5YN/A
F-Score5
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 25.07%
Cap/Sales 2.54%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.12
Quick Ratio 2.83
Altman-Z 0.02
F-Score5
WACC10.52%
ROIC/WACCN/A
Cap/Depr(3y)50.98%
Cap/Depr(5y)123.25%
Cap/Sales(3y)9.86%
Cap/Sales(5y)22.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)70.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%39.33%
EPS Next Y70.65%
EPS Next 2Y30.73%
EPS Next 3Y20.29%
EPS Next 5Y25.69%
Revenue 1Y (TTM)51.12%
Revenue growth 3Y63.94%
Revenue growth 5YN/A
Sales Q2Q%26.41%
Revenue Next Year33.9%
Revenue Next 2Y32.42%
Revenue Next 3Y39.02%
Revenue Next 5Y69.79%
EBIT growth 1Y44.93%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year83.13%
EBIT Next 3Y26.31%
EBIT Next 5YN/A
FCF growth 1Y49.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y49.36%
OCF growth 3YN/A
OCF growth 5YN/A